Tarbox Family Office’s iShares Biotechnology ETF IBB Stock Holding History

Tarbox Family Office’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-631	Closed	-$76K	–	1209
2019 Q4	$76K	Hold	631	–	–	0.02%	154
2019 Q3	$63K	Hold	631	–	–	0.02%	148
2019 Q2	$69K	Hold	631	–	–	0.02%	146
2019 Q1	$71K	Hold	631	–	–	0.03%	132
2018 Q4	$61K	Hold	631	–	–	0.03%	134
2018 Q3	$77K	Sell	631 -428	-40%	-$50.4K	0.03%	131
2018 Q2	$116K	Hold	1,059	–	–	0.04%	112
2018 Q1	$113K	Hold	1,059	–	–	0.04%	118
2017 Q4	$113K	Hold	1,059	–	–	0.04%	116
2017 Q3	$118K	Hold	1,059	–	–	0.05%	108
2017 Q2	$109K	Hold	1,059	–	–	0.05%	109
2017 Q1	$104K	Buy	+1,059	New	+$101K	0.05%	94

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tarbox Family Office's IBB Position: Q1 2020 in Review

Tarbox Family Office sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 631 shares — an estimated $76K sold.

Tarbox Family Office first reported a position in IBB in Q1 2017 and held it in 12 quarters. The position peaked at $118K in Q3 2017. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Tarbox Family Office reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Tarbox Family Office sold 631 iShares Biotechnology ETF shares in Q1 2020, an estimated $76K.
Tarbox Family Office first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 12 quarters.
Tarbox Family Office's iShares Biotechnology ETF position peaked at $118K in Q3 2017.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Tarbox Family Office's 13F filing for Q1 2020, filed 30 Apr 2020.